Found: 6
Select item for more details and to access through your institution.
Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 1, p. 1, doi. 10.1016/S0009-9236(96)90016-8
- By:
- Publication type:
- Article
Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factor.
- Published in:
- Transfusion, 2015, v. 55, n. 5, p. 1021, doi. 10.1111/trf.12979
- By:
- Publication type:
- Article
Splenectomy for the treatment of thrombotic thrombocytopenic purpura.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 5, p. 768, doi. 10.1111/j.1365-2141.2005.05681.x
- By:
- Publication type:
- Article
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 2, p. 319, doi. 10.1046/j.1365-2141.2001.02926.x
- By:
- Publication type:
- Article
The low cycling status of mobilized peripheral blood CD34+ cells is not restricted to the more primitive subfraction.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45358-0
- By:
- Publication type:
- Article